Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6703307 | 7375519 | F | 6703307-8 | 20100201 | 20100416 | 20100428 | EXP | THQ2010A00915 | TAKEDA PHARMACEUTICALS NORTH AMERICA. | 68 | YR | F | N | 20100427 | GREECE |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6703307 | 1013598456 | PS | ACTOS | 1 | ORAL | 30 MG (30 MG, 1 IN 1 D) PER ORAL | D | 21073 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6703307 | 1013598456 | TYPE 2 DIABETES MELLITUS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6703307 | OT |
Reactions reported
| Event ID | PT |
|---|---|
| 6703307 | PAPILLOEDEMA |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 6703307 | FGN |
| 6703307 | HP |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6703307 | 1013598456 | 20070101 | 20100301 | 3 | YR |